XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
170 hedge funds and large institutions have $1.98B invested in Acceleron Pharma in 2018 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 60 increasing their positions, 38 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
13% more funds holding
Funds holding: 150 → 170 (+20)
49% less call options, than puts
Call options by funds: $32.5M | Put options by funds: $64.4M
Holders
170
Holding in Top 10
6
Calls
$32.5M
Puts
$64.4M
Top Buyers
| 1 | +$59.8M | |
| 2 | +$32.1M | |
| 3 | +$24.8M | |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
+$21M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$14.3M |
Top Sellers
| 1 | -$37M | |
| 2 | -$28.1M | |
| 3 | -$21.8M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$16.4M |
| 5 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
-$13.8M |